‘ ’ . [=] 65 . MD (New England Journal of Medicine) 3( ) . 3~7 (ASCO) (SHINE 3 ) . 65 ( ) (progression-free survival) . , . ( ) (Pharmacyclics) . 261() . 262() . . 6 , . ( 84.7) () 80.6 … [+179 chars]
19 , . [=JV_WONSUNG/] A(39) (7) , 19 . . A . A 19 , . 19 ? , . “ ” . . . · . , . ‘ ’ . 19 19 . , , . . 90%, 99% . pomy80@kormedi.com ' ' (https://kormedi.com) / -
5 6 . . 19 . . , , , , …. 39 . , , . …. . , . . . . . . . . ‘ . . ?’ . . 100 . , (CNBIO) . ‘ Clean-4’. , , , . 5 . 7 ‘ (Clean)-4’ . “ . .” . “ ” “ , ” . “ . “ , . , . , .” (CNBIO) (56)… [+507 chars]
‘ ’ . [=] 65 . MD (New England Journal of Medicine) 3( ) . 3~7 (ASCO) (SHINE 3 ) . 65 ( ) (progression-free survival) . , . ( ) (Pharmacyclics) . 261() . 262() . . 6 , . ( 84.7) () 80.6 … [+179 chars]
, . 99% , . . . Q. ?. , , , . . Q. ?. , . 1~4 , 2 3. Q. 2 3 ?2 1 , , () . 3 , . 3 2 . Q. ?4 . 4 . ( 14 ) . Q. ?1 21 7 . 7 , 1~2 . . 7 7 . Q. ?7~10 1 . 1~2 . Q. ?12 1 . 12 . 1 2 7 . 2 2 . 7 . 3… [+80 chars]
10 20.7 (34.8) . 40 50 .(2018 ) . ' ' , 2000 23 2019 34, 10 48% . . . B , . . , . , 2 , . , . , , . , , . ' '. B C . B 100 . , , . . 6, 4 . 50~59 . ' ' . , , () . , . , . . (Alpha-Fet… [+135 chars]
, , . (mucolytic bacteria) (Nature Partner Journals Parkinson's Disease) . 165. 2 . (Hoehn-Yahr) 1 . . 3 . , 2 . . " , " .
[ = ] . [=AP] (Euro Surveillance) , 7 . 4 , , , (HIV) . 3 . . . . 3 , . . 4 , , 3 . 1 . 5() (CDC) , 911 36 . 225 , 186 . , , , . < , (www.asiae.co.kr) >
[=] . . . . T . . () . (DC) . T . . T. T . T . . T(Cytotoxic T cell) T(Helper T cell) . T T . T . (live-cell imaging) 6 T , , . . . , , . T . 8% T . hanguru@kormedi.com ' ' (https://… [+15 chars]
, . GP Rachel Ward . 7 “ , , . “ , , . “ .” Lynsey Hope . ? . Emma McConnachie . 7 . , , . . “ .” ? . 30 45% . 7 . 40 47 2,000 , . “ 29~45% .” . . . 7 900 100 . DNA . … [+196 chars]
[= ] (19) . . 1 , 19 B(NB-UVB) 7() . () ‘(Experimental Dermatology)’ . 2021 5 24 8 16 19 30 . 50~95 , 94% . , , . 15 311(nm) NB-UVB , 8 24 27% . , 28 NB-UVB 13.3% 33.3% 20%p() . , . NB-UVB .… [+98 chars]
19 50% . . /= (19) .6 19 . 2020 5 2021 2 1394 4142 19 . 147 261 19 , , , . 19 . 19 50% . 2(ACE2) . 19 ACE2 . ACE2 . , (BMI) 19 . 320 19 41% , BMI 10 19 9% . 31 '(Journal of Allergy and Cli… [+42 chars]
